Title
Pharmaceutical Manufacturing Efficiency, Drug Prices, And Public Health: Examining The Causal Links
Keywords
Drug prices; Pharmaceutical manufacturing; R&; D
Abstract
There are important fundamental links among the efficiency of pharmaceutical manufacturing, drug prices, and public health in the United States. This article seeks to probe these links because recent research (by academics and even the US Food and Drug Administration) suggests there are significant opportunities to improve the manufacturing processes for pharmaceuticals. Two models are developed that consider the impact of reduced manufacturing costs on pharmaceutical prices and firm profits. The two models effectively bound the range of potential future benefits from greater manufacturing efficiency and estimate that, for example, a 30% reduction in manufacturing costs will generate between $1.0 and $ 12.3 trillion in social value to the United States. Copyright © 2007 Drug Information Association, Inc.
Publication Date
1-1-2007
Publication Title
Drug Information Journal
Volume
41
Issue
2
Number of Pages
229-239
Document Type
Article; Proceedings Paper
Personal Identifier
scopus
DOI Link
https://doi.org/10.1177/009286150704100217
Copyright Status
Unknown
Socpus ID
33947201624 (Scopus)
Source API URL
https://api.elsevier.com/content/abstract/scopus_id/33947201624
STARS Citation
Vernon, John A.; Hughen, W. Keener; and Trujillo, Antonio J., "Pharmaceutical Manufacturing Efficiency, Drug Prices, And Public Health: Examining The Causal Links" (2007). Scopus Export 2000s. 7490.
https://stars.library.ucf.edu/scopus2000/7490